This study investigates the response of vaginal and cervical tissue after exposure to three
vaginal products: hydroxyethyl cellulose (HEC) placebo, nonoxynol-9 (N9) and imiquimod (IMQ)
We will connect you to the doctor responsible for this trial and help you get more information.
Locations near you
Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Full eligibility criteria for NCT01593124
Ages eligible for Study
21 Years to 45 Years
Genders eligible for Study
Accepts Healthy Volunteers
21 to 45 years of age, inclusive;
In good health, as evidenced by history and procedures at screening and enrollment visits without any clinically significant systemic disease;
Not be at risk for pregnancy, due to surgical sterilization of participant and or her sexual partner, abstinence for duration of study, consistent condom use, non-hormonal IUD or same sex relationship. Note: If consistent condom user, must agree to use condoms without spermicide for duration of study.;
Have had regular menstrual cycles (every 24-35 days) for the past two cycles;
Willing and able to comply with study procedures
A clinically significant history of an abnormal pap smear (by written report) that has not been evaluated and or treated, if indicated, according to standard guidelines;
It has been less than 9 months since the participant's last depot medroxyprogesterone acetate (DMPA) injection and she has not had 2 normal, spontaneous menses (this can be shortened to 6 months if the participant has had at least 2 normal spontaneous menses);
Use of any other hormonal contraceptive method within past 3 months (oral, transdermal, transvaginal, implant, or intrauterine device) without 2 subsequent, normal menses;
Surgery or biopsy of the vulva, vagina, or cervix (including piercings) within 30 days;
Pregnancy within the past 3 months;
Current STI or lower genital tract infection (including, but not limited to HIV-1, HSV-2, Chlamydia trachomatis (CT), Trichomonas vaginalis (TV), Neisseria Protocol # D11-119 Version 2.0 April 13, 2012 10 gonorrhea (NG), Hepatitis B, high risk HPV sub types and or Syphilis), yeast vaginitis or bacterial vaginosis (BV);
Current use of chronic immunosuppressants (for example daily steroids or daily non-steroidal anti-inflammatory drugs [NSAIDs]);
Current presence of vulvar, anal and or vaginal genital warts;
Current tobacco use of any amount;
Other conditions that, in the opinion of the investigator, would constitute contraindications to participation in the study or would compromise the ability to comply with study protocols, such as any major chronic illness including but not limited to cancer, serious autoimmune disease, metabolic disorders or a major psychiatric disorder (e.g., schizophrenia); and
Current participation in any other drug or device study, or any study which, in the
All locations for NCT01593124
United States (1)
Eastern Virginia Medical School CONRAD Clinical Research Center
Norfolk, Virginia, United States, 23507
View full eligibility
Tris trial is registered with FDA with number: NCT01593124. The sponsor of the trial is CONRAD and it is looking for 20 volunteers for the current phase.
Official trial title: Identification of Novel Biomarkers of Cervicovaginal Mucosal Inflammation
1What's a trial
4Get in touch
What's a trial
Not sure you're well informed about clinical trials? Learn more about their benefits, risks and other important details.
Enter your details like condition, age, gender and other preferences and we will show you a list of all relevant clinical trials.
Review the summary of the selected clinical trial and all the locations near you in order to see if it's of interest to you.
Get in touch
You've found an interesting trial? We'll need a bit more information about you so we can connect you to the doctor in charge.
Some people want to consult their doctor before considering participation in a clinical trial. This is absolutely normal as your doctor should know your medical history and should be able to advise you. If you want you can easily share the information for this trial with your doctor by clicking on the button below.